|
1
|
Venook AP, Papandreou C, Furuse J and de
Guevara LL: The incidence and Epidemiology of hepatocellular
carcinoma: A global and regional perspective. Oncologist. 15(Suppl
4): S5–S13. 2010. View Article : Google Scholar
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arzumanyan A, Reis HM and Feitelson MA:
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular
carcinoma. Nat Rev Cancer. 13:123–135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fonseca AL and Cha CH: Hepatocellular
carcinoma: A comprehensive overview of surgical therapy. J Surg
Oncol. 110:712–719. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Raza A and Sood GK: Hepatocellular
carcinoma review: Current treatment, and evidence-based medicine.
World J Gastroenterol. 20:4115–4127. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Frenette C and Gish R: Targeted systemic
therapies for hepatocellular carcinoma: Clinical perspectives,
challenges and implications. World J Gastroenterol. 18:498–506.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wei Z, Doria C and Liu Y, Wei Y, Doria C
and Liu Y: Targeted therapies in the treatment of advanced
hepatocellular carcinoma. Clin Med Insights Oncol. 7:87–102. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jeng KS, Chang CF, Jeng WJ, Sheen IS and
Jeng CJ: Heterogeneity of hepatocellular carcinoma contributes to
cancer progression. Crit Rev Oncol Hematol. 94:337–347. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bayo J, Marrodán M, Aquino JB, Silva M,
Garcia MG and Mazzolini G: The therapeutic potential of bone
marrow-derived mesenchymal stromal cells on hepatocellular
carcinoma. Liver Int. 34:330–342. 2014. View Article : Google Scholar
|
|
10
|
Ho IA, Toh HC, Ng WH, Teo YL, Guo CM, Hui
KM and Lam PY: Human bone marrow-derived mesenchymal stem cells
suppress human glioma growth through inhibition of angiogenesis.
Stem Cells. 31:146–155. 2013. View Article : Google Scholar
|
|
11
|
Long X, Matsumoto R, Yang P and Uemura T:
Effect of human mesenchymal stem cells on the growth of HepG2 and
Hela cells. Cell Struct Funct. 38:109–121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bruno S, Collino F, Deregibus MC, Grange
C, Tetta C and Camussi G: Microvesicles derived from human bone
marrow mesenchymal stem cells inhibit tumor growth. Stem Cells Dev.
22:758–771. 2013. View Article : Google Scholar
|
|
13
|
Zhang L, Su XS, Ye JS, Wang YY, Guan Z and
Yin YF: Bone marrow mesenchymal stem cells suppress metastatic
tumor development in mouse by modulating immune system. Stem Cell
Res Ther. 6:452015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li WQ, Li YM, Guo J, Liu YM, Yang XQ, Ge
HJ, Xu Y, Liu HM, He J and Yu HY: Hepatocytic precursor (stem-like)
WB-F344 cells reduce tumorigenicity of hepatoma CBRH-7919 cells via
TGF-β/Smad pathway. Oncol Rep. 23:1601–1607. 2010.PubMed/NCBI
|
|
15
|
Peters SJ, Vanhaecke T, Papeleu P, Rogiers
V, Haagsman HP and van Norren K: Co-culture of primary rat
hepatocytes with rat liver epithelial cells enhances
interleukin-6-induced acute-phase protein response. Cell Tissue
Res. 340:451–457. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsao MS, Smith JD, Nelson KG and Grisham
JW: A diploid epithelial cell line from normal adult rat liver with
phenotypic properties of ʻovalʼ cells. Exp Cell Res. 154:38–52.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Masson NM, Currie IS, Terrace JD, Garden
OJ, Parks RW and Ross JA: Hepatic progenitor cells in human fetal
liver express the oval cell marker Thy-1. Am J Physiol Gastrointest
Liver Physiol. 291:G45–G54. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Petersen BE, Goff JP, Greenberger JS and
Michalopoulos GK: Hepatic oval cells express the hematopoietic stem
cell marker Thy-1 in the rat. Hepatology. 27:433–445. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yovchev MI, Grozdanov PN, Joseph B, Gupta
S and Dabeva MD: Novel hepatic progenitor cell surface markers in
the adult rat liver. Hepatology. 45:139–149. 2007. View Article : Google Scholar
|
|
20
|
Hao PP, Lee MJ, Yu GR, Kim IH, Cho YG and
Kim DG: Isolation of EpCAM+/CD133− hepatic
progenitor cells. Mol Cells. 36:424–431. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ni Z, Wang B, Dai X, Ding W, Yang T, Li X,
Lewin S, Xu L, Lian J and He F: HCC cells with high levels of Bcl2
are resistant to ABT-737 via activation of the ROS-JNK-autophagy
pathway. Free Radic Biol Med. 70:194–203. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: Diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stivarou T and Patsavoudi E: Extracellular
molecules involved in cancer cell invasion. Cancers. 7:238–265.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ponte AL, Marais E, Gallay N, Langonné A,
Delorme B, Hérault O, Charbord P and Domenech J: The in vitro
migration capacity of human bone marrow mesenchymal stem cells:
Comparison of chemokine and growth factor chemotactic activities.
Stem Cells. 25:1737–1745. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pietras K, Pahler J, Bergers G and Hanahan
D: Functions of paracrine PDGF signaling in the proangiogenic tumor
stroma revealed by pharmacological targeting. PLoS Med. 5:e192008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Watnick RS: The role of the tumor
microenvironment in regulating angiogenesis. Cold Spring Harb
Perspect Med. 2:a0066762012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhong XG, He S, Yin W, Deng JY and Cheng
B: Selective tropism of liver stem cells to hepatocellular
carcinoma in vivo. World J Gastroenterol. 13:3886–3891. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang J, Lam DH, Goh SS, Lee EX, Zhao Y,
Tay FC, Chen C, Du S, Balasundaram G, Shahbazi M, et al: Tumor
tropism of intravenously injected human-induced pluripotent stem
cell-derived neural stem cells and their gene therapy application
in a metastatic breast cancer model. Stem Cells. 30:1021–1029.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu YR, Yuan Y, Wang XJ, Wei LL, Chen YN,
Cong C, Li SF, Long D, Tan WD, Mao YQ, et al: The growth inhibitory
effect of mesenchymal stem cells on tumor cells in vitro and in
vivo. Cancer Biol Ther. 7:245–251. 2008. View Article : Google Scholar
|
|
30
|
Ramasamy R, Lam EW, Soeiro I, Tisato V,
Bonnet D and Dazzi F: Mesenchymal stem cells inhibit proliferation
and apoptosis of tumor cells: Impact on in vivo tumor growth.
Leukemia. 21:304–310. 2007. View Article : Google Scholar
|
|
31
|
Khakoo AY, Pati S, Anderson SA, Reid W,
Elshal MF, Rovira II, Nguyen AT, Malide D, Combs CA, Hall G, et al:
Human mesenchymal stem cells exert potent antitumorigenic effects
in a model of Kaposi's sarcoma. J Exp Med. 203:1235–1247. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Elzaouk L, Moelling K and Pavlovic J:
Anti-tumor activity of mesenchymal stem cells producing IL-12 in a
mouse melanoma model. Exp Dermatol. 15:865–874. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li GC, Ye QH, Xue YH, Sun HJ, Zhou HJ, Ren
N, Jia HL, Shi J, Wu JC, Dai C, et al: Human mesenchymal stem cells
inhibit metastasis of a hepatocellular carcinoma model using the
MHCC97-H cell line. Cancer Sci. 101:2546–2553. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Y, Fan H, Zhou B, Ju Z, Yu L, Guo L,
Han J and Lu S: Fusion of human umbilical cord mesenchymal stem
cells with esophageal carcinoma cells inhibits the tumorigenicity
of esophageal carcinoma cells. Int J Oncol. 40:370–377. 2012.
|
|
35
|
Qiao L, Xu Z, Zhao T, Zhao Z, Shi M, Zhao
RC, Ye L and Zhang X: Suppression of tumorigenesis by human
mesenchymal stem cells in a hepatoma model. Cell Res. 18:500–507.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ganta C, Chiyo D, Ayuzawa R, Rachakatla R,
Pyle M, Andrews G, Weiss M, Tamura M and Troyer D: Rat umbilical
cord stem cells completely abolish rat mammary carcinomas with no
evidence of metastasis or recurrence 100 days post-tumor cell
inoculation. Cancer Res. 69:1815–1820. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu W, Xu W, Jiang R, Qian H, Chen M, Hu
J, Cao W, Han C and Chen Y: Mesenchymal stem cells derived from
bone marrow favor tumor cell growth in vivo. Exp Mol Pathol.
80:267–274. 2006. View Article : Google Scholar
|
|
38
|
Djouad F, Plence P, Bony C, Tropel P,
Apparailly F, Sany J, Noël D and Jorgensen C: Immunosuppressive
effect of mesenchymal stem cells favors tumor growth in allogeneic
animals. Blood. 102:3837–3844. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jung Y, Kim JK, Shiozawa Y, Wang J, Mishra
A, Joseph J, Berry JE, McGee S, Lee E, Sun H, et al: Recruitment of
mesenchymal stem cells into prostate tumours promotes metastasis.
Nat Commun. 4:17952013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Karnoub AE, Dash AB, Vo AP, Sullivan A,
Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R and Weinberg
RA: Mesenchymal stem cells within tumour stroma promote breast
cancer metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Aquino JB, Bolontrade MF, García MG,
Podhajcer OL and Mazzolini G: Mesenchymal stem cells as therapeutic
tools and gene carriers in liver fibrosis and hepatocellular
carcinoma. Gene Ther. 17:692–708. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li GC, Ye QH, Dong QZ, Ren N, Jia HL and
Qin LX: Mesenchymal stem cells seldomly fuse with hepatocellular
carcinoma cells and are mainly distributed in the tumor stroma in
mouse models. Oncol Rep. 29:713–719. 2013.
|
